Health-care companies ticked down as traders rotated into cyclical sectors, betting on benign inflation data.
Shareholders sued Mallinckrodt, alleging the struggling pharmaceutical company made false and misleading statements about its financial health that resulted in investor losses.
The European Medicines Agency confirmed it's reviewing data on the risk of suicidal thoughts and self-harm stemming from the use of a new class of weight-loss drugs after Iceland's medical regulator reported self-injury and suicidal thoughts in people using Ozempic, Saxenda and Wegovy.
NanoViricides shares surged after the drug developer said an antiviral candidate, NV-387, showed effectiveness in an animal model infected with respiratory syncytial virus, or RSV.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
07-11-23 1752ET
